| Literature DB >> 32937134 |
Benedict D Michael1, Laura Bricio-Moreno2, Elizabeth W Sorensen2, Yoshishige Miyabe3, Jeffrey Lian2, Tom Solomon4, Evelyn A Kurt-Jones5, Andrew D Luster6.
Abstract
Herpes simplex virus (HSV)-1 encephalitis has significant morbidity partly because of an over-exuberant immune response characterized by leukocyte infiltration into the brain and increased blood-brain barrier (BBB) permeability. Determining the role of specific leukocyte subsets and the factors that mediate their recruitment into the brain is critical to developing targeted immune therapies. In a murine model, we find that the chemokines CXCL1 and CCL2 are induced in the brain following HSV-1 infection. Ccr2 (CCL2 receptor)-deficient mice have reduced monocyte recruitment, uncontrolled viral replication, and increased morbidity. Contrastingly, Cxcr2 (CXCL1 receptor)-deficient mice exhibit markedly reduced neutrophil recruitment, BBB permeability, and morbidity, without influencing viral load. CXCL1 is produced by astrocytes in response to HSV-1 and by astrocytes and neurons in response to IL-1α, and it is the critical ligand required for neutrophil transendothelial migration, which correlates with BBB breakdown. Thus, the CXCL1-CXCR2 axis represents an attractive therapeutic target to limit neutrophil-mediated morbidity in HSV-1 encephalitis.Entities:
Keywords: CXCL1; CXCR2; HSV; chemokines; encephalitis; migration; neutrophil; viral
Mesh:
Substances:
Year: 2020 PMID: 32937134 PMCID: PMC7548103 DOI: 10.1016/j.celrep.2020.108150
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423